DRUG EMPORIUM INC
10-Q, EX-10.2, 2000-10-11
DRUG STORES AND PROPRIETARY STORES
Previous: DRUG EMPORIUM INC, 10-Q, EX-10.1, 2000-10-11
Next: DRUG EMPORIUM INC, 10-Q, EX-18, 2000-10-11



<PAGE>   1
                                                                  Exhibit 10.2


                SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT
                ------------------------------------------------

                  This Seventh Amendment to Loan and Security Agreement (the
         "Seventh Amendment") is made as of this __ day of September, 2000 by
         and between

                  Fleet Retail Finance Inc., formerly known as BankBoston Retail
         Finance Inc. (in such capacity, herein the "Agent"), a Delaware
         corporation with offices at 40 Broad Street, Boston, Massachusetts
         02109, as agent for the ratable benefit of the "Lenders", who are party
         to the Agreement (defined below)

                                       and

                  Back Bay Capital Funding LLC, a Delaware Limited Liability
         Company with offices at 40 Broad Street, Boston, Massachusetts 02109
         (the "Term Lender")

                                       and

                  Drug Emporium, Inc. (hereinafter, the "Borrower"), a Delaware
         corporation with its principal executive offices at 155 Hidden Ravines
         Drive, Powell, Ohio 43065

in consideration of the mutual covenants herein contained and benefits to be
derived herefrom.

                              W I T N E S S E T H:

         WHEREAS, on October 28, 1998 the Agent, the Lenders and the Borrower
entered in a certain Loan and Security Agreement, as amended by a First
Amendment to Loan and Security Agreement dated May 11, 1999, a Second Amendment
to Loan and Security Agreement dated September 15, 1999, a Third Amendment to
Loan and Security Agreement dated December 10, 1999, a Fourth Amendment to Loan
and Security Agreement dated March 8, 2000, a Fifth Amendment to Loan and
Security Agreement dated May 10, 2000, and a Sixth Amendment to Loan and
Security Agreement dated August 18, 2000 (the "Agreement"); and

         WHEREAS, the Borrower, the Agent, the Lenders, and the Term Lender
desire to amend certain of the provisions of the Agreement;

         NOW, THEREFORE, it is hereby agreed among the Agent, the Lenders, the
Term Lender, and the Borrower as follows:



                                      -1-
<PAGE>   2

1. CAPITALIZED TERMS. All capitalized terms used herein and not otherwise
defined shall have the same meaning herein as in the Agreement.

2.

3. WAIVER OF COMPLIANCE WITH SECTIONS 4-18, 4-19, 4-20 AND 4-23. The Lenders
waive compliance by the Borrower with the terms of Sections 4-18, 4-19, 4-20 and
4-23 of the Agreement in connection with the investments in and/or loans to be
made in connection with the continued operation of Borrower's commerce business
("E-Commerce", which term includes DrugEmporium.com Inc. and the business to be
carried on by it), including without limitation, any amount invested in,
advanced to or paid or incurred by or on behalf of E-Commerce up to a maximum
aggregate amount of $38,500,00.00.

4.

5. AMENDMENT TO ARTICLE 5. Section 5-12 of the Agreement is hereby amended to
read as follows:

6.

                           (a) EBITDA: The Borrower shall not permit or suffer
                  its EBITDA, tested as of the last day of each fiscal quarter
                  on the basis set forth below, to be less than the following:

                          MINIMUM CONSOLIDATED EBITDA:

                              "()" Denotes Negative

<TABLE>
<CAPTION>
    ===========================================================================
             BASIS TESTED                                       MINIMUM EBITDA
    ===========================================================================
<S>                                                              <C>
             Three Quarters Ending August, 2000                  ($21,200,000)
    ---------------------------------------------------------------------------
            Four Quarters Ending November, 2000                  ($19,500,000)
    ---------------------------------------------------------------------------
            Four Quarters Ending February, 2001                   ($2,000,000)
    ===========================================================================
</TABLE>

For fiscal quarters thereafter, minimum EBITDA shall be established based upon
reasonable projections prepared by the Borrower and agreed upon by the Agent.

1. AMENDMENT TO ARTICLE 5. Section 5-14 of the Agreement is hereby amended to
read as follows:

2.

                           5-14. MINIMUM EXCESS AVAILABILITY. Availability after
                  giving effect to all then held checks (if any); accounts
                  payable which are beyond credit terms then accorded the
                  Borrower and overdrafts shall not be less than $10,000,000.00,
                  measured on a rolling thirty (30) day average basis, provided,
                  however, for the month of November, 2000, only, Availability
                  shall not be less than $7,500,000.00.

1. RATIFICATION OF LOAN DOCUMENTS. Except as provided herein, all terms and
conditions of the Agreement and of the other Loan Documents remain in full force
and effect. Furthermore, except as provided herein, all warranties and
representations made in the Agreement and in the other Loan Documents remain in
full force and effect.


                                      -2-
<PAGE>   3

2.

3. CONDITIONS TO EFFECTIVENESS. This Seventh Amendment shall not be effective
until each of the following conditions precedent have been fulfilled to the
satisfaction of the Agent and the Lenders:

4.

         (a) This Seventh Amendment shall have been duly executed and delivered
         by the all necessary parties hereto.

         (a) No Suspension Event shall have occurred and be continuing.

         (a) The Borrower shall have provided such additional instruments and
         documents to the Agent as the Agent and the Agent's counsel may have
         reasonably requested.

         (a) DrugEmporium.com Inc. shall have executed and delivered to the
         Borrower, a promissory note in the principal amount of $38,500,000.00
         and a Pledge Agreement, each in form and substance satisfactory to the
         Agent, pursuant to which DrugEmporium.com Inc. shall have pledged to
         the Borrower 480,000 shares of preferred stock of Healthcentral.com,
         Inc., such promissory note and Pledge Agreement to be assigned to the
         Agent, for the benefit of the Lenders.

         (a) The Agent, the Lenders, and the Borrower shall execute a Consent
         Agreement in the form annexed hereto.

         (a) The Agent shall promptly notify the Borrower when such conditions
         are satisfied.

         (a) The Borrower shall have furnished the Agent with corporate
         resolutions authorizing the execution of this Amendment and the
         documents contemplated herein.

1.       MISCELLANEOUS.

2.

         (a) This Seventh Amendment may be executed in several counterparts and
         by each party on a separate counterpart, each of which when so executed
         and delivered shall be an original, and all of which together shall
         constitute one instrument.

         (a) This Seventh Amendment expresses the entire understanding of the
         parties with respect to the transactions contemplated hereby. No prior
         negotiations or discussions shall limit, modify, or otherwise affect
         the provisions



                                      -3-
<PAGE>   4


         hereof.

         (a) Any determination that any provision of this Seventh Amendment or
         any application hereof is invalid, illegal or unenforceable in any
         respect and in any instance shall not effect the validity, legality, or
         enforceability of such provision in any other instance, or the
         validity, legality or enforceability of any other provisions of this
         Seventh Amendment.

         (a) The Borrower shall pay on demand all costs and expenses of the
         Agent, including, without limitation, reasonable attorneys' fees, in
         connection with the preparation, negotiation, execution and delivery of
         this Seventh Amendment.

         (a) The Borrower warrants and represents that the Borrower has
         consulted with independent legal counsel of the Borrower's selection in
         connection with this Seventh Amendment and is not relying on any
         representations or warranties of any Lender or the Agent or their
         respective counsel in entering into this Seventh Amendment.

         IN WITNESS WHEREOF, the parties have caused this Seventh Amendment to
Loan and Security Agreement to be executed by their duly authorized officers as
a sealed instrument as of the date first above written.

                                          DRUG EMPORIUM, INC.
                                          ("Borrower")

                                          By:
                                             -----------------------------------
                                          Name:
                                               ---------------------------------
                                          Title:
                                                --------------------------------


                                          FLEET RETAIL FINANCE INC.
                                          ("Agent")


                                          By:
                                             -----------------------------------
                                          Name:
                                               ---------------------------------
                                          Title:
                                                --------------------------------



                                      -4-
<PAGE>   5


                                      The "LENDERS"

                                          FLEET RETAIL FINANCE INC.


                                          By
                                            ------------------------------------
                                          Print Name:
                                                     ---------------------------
                                          Title:
                                                --------------------------------



                                      -5-
<PAGE>   6



                                          NATIONAL CITY COMMERCIAL FINANCE, INC.


                                          By
                                            ------------------------------------
                                          Print Name:
                                                     ---------------------------
                                          Title:
                                                --------------------------------

                                          AMERICAN NATIONAL BANK AND
                                          TRUST COMPANY OF CHICAGO


                                          By
                                            ------------------------------------
                                          Print Name:
                                                     ---------------------------
                                          Title:
                                                --------------------------------

                                          LASALLE BUSINESS CREDIT, INC.


                                          By
                                            ------------------------------------
                                          Print Name:
                                                     ---------------------------
                                          Title:
                                                --------------------------------

                                          BACK BAY CAPITAL FUNDING LLC


                                          By
                                            ------------------------------------
                                          Print Name:
                                                     ---------------------------
                                          Title:
                                                --------------------------------




                                      -6-


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission